World Health Organization calls for more support to develop vCJD tests
This article was originally published in Clinica
Executive Summary
Attempts to develop and validate tests to detect variant Creutzfeldt-Jakob disease (vCJD) infectivity in blood should be encouraged, both financially and by providing developers with TSE reference materials and panels of coded and randomised samples. That is the view of the World Health Organization in new guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies.